Rollout of high-priced cell and gene therapies forces payer rethink

Nature Biotechnology 36, 291 (2018).
doi:10.1038/nbt0418-291a

Author: Melanie Senior

Source: Nature Biotechnology - April 5, 2018 Category: Biotechnology Authors: Melanie Senior Tags: News Source Type: research